Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferroglycine sulfate is an oral iron(II) complex used for the treatment and prevention of iron deficiency and iron deficiency anemia. It consists of ferrous sulfate chelated with the amino acid glycine, a formulation designed to improve gastrointestinal tolerability and enhance iron absorption compared to standard ferrous salts. By providing a source of elemental iron, it supports the synthesis of hemoglobin in red blood cells and myoglobin in muscle tissues, as well as the function of various iron-dependent enzymes. It is commonly marketed under the brand name Ferro-Sanol and is often administered as enteric-coated capsules to minimize gastric irritation and ensure release in the upper small intestine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferroglycine sulfate.